
zzso is common in many patients with cancer treated with zzso One option for managing zzso anemia zzso is zzso proteins zzso which are indicated for the treatment of zzso in patients with most types of zzso They have been shown to be safe and effective in numerous well-documented studies, and their side effects are well zzso The rate of zzso events with the zzso zzso zzso zzso zzso has been consistent in studies conducted before and after its zzso The association of zzso events with high zzso levels or rapid increases in its levels in patients with cancer remains zzso zzso the dose of the zzso to maintain and monitor a target zzso level of 11 to 12 zzso is certainly prudent and may help prevent or minimize these zzso zzso anemia has been associated with shorter survival in patients with cancer, and the relation is likely zzso Data on the treatment of zzso with zzso have not shown a consistent effect on zzso Two studies in patients with zzso levels above the target level showed that survival was shorter in the patients treated with zzso A review of data from other trials found no effect of zzso on survival, and other trials suggested a positive zzso This article reviews data on survival in patients treated with zzso and discusses five large zzso controlled trials of zzso zzso that are addressing this zzso 

